Built on published work.
The platform rests on peer-reviewed research in neural stem cell biology, brain tumour initiating cells and intercellular mitochondrial transfer.
Built on published work.
Approach.
Human tissue, human answers
Animal models answer human questions by analogy. Organoids grown from human cells answer them directly. That is the whole argument for the platform, and it is why the effort goes into making human tissue reproducible rather than into making animal work more elaborate.
One genome, many tissues
Work that traces back to a single characterised line can be compared across tissues and across years. Work that does not, cannot. This constraint shapes every protocol we write.
Mechanism before therapy
We work on the mechanism and the model system. Translation follows evidence rather than leading it, and we would rather publish a negative result than imply a positive one.
Selected publications.
Intercellular mitochondrial transfer from human neural stem cells and brain tumour initiating cells into neighbouring astrocytes
Characterisation of brain tumour initiating cells from an animal model of CNS primitive neuroectodermal tumours
A mouse model of radial glial cell-derived primitive neuroectodermal tumours
Onset of rosette formation during spontaneous neural differentiation of hESC and hiPSC colonies
Methods and standards.
Pluripotency, karyotype, identity and sterility verified before a line enters the bank.
Bioreactor conditions, density and timing controlled and recorded at every step.
Results held with their metadata so that a finding can be traced back to the line it came from.
Consented material, auditable use, and precision about what a model is and is not.
What we do not claim.
TAKWYN's work is research-stage. Nothing on this site is a diagnostic or therapeutic claim, and no treatment is offered or available. Organoids are models of developing tissue: useful for asking questions about human biology, and not substitutes for the organs they are named after. Where we describe a long-horizon goal, we label it as one.
